The Cooper Companies, Inc. (NASDAQ:COO) Receives Consensus Recommendation of "Hold" from Analysts

Shares of The Cooper Companies, Inc. (NASDAQ:COO - Get Free Report) have earned an average recommendation of "Hold" from the seventeen ratings firms that are currently covering the stock, Marketbeat.com reports. Three research analysts have rated the stock with a sell rating, six have assigned a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company. The average twelve-month target price among analysts that have issued ratings on the stock in the last year is $81.3571.

Several research analysts recently issued reports on COO shares. Mizuho set a $85.00 target price on shares of Cooper Companies and gave the stock an "outperform" rating in a research note on Thursday, June 4th. JPMorgan Chase & Co. dropped their price objective on shares of Cooper Companies from $80.00 to $71.00 and set a "neutral" rating on the stock in a report on Friday, June 5th. BNP Paribas Exane cut their price objective on shares of Cooper Companies from $95.00 to $92.00 and set an "outperform" rating on the stock in a research report on Monday, June 8th. The Goldman Sachs Group set a $61.00 target price on Cooper Companies in a research report on Wednesday, May 27th. Finally, Needham & Company LLC dropped their price target on Cooper Companies from $101.00 to $86.00 and set a "buy" rating on the stock in a research note on Friday, June 5th.

Cooper Companies Stock Down 2.0%

Shares of Cooper Companies stock opened at $73.32 on Friday. The stock's 50-day moving average is $69.37 and its 200 day moving average is $71.49. Cooper Companies has a one year low of $58.89 and a one year high of $89.83. The firm has a market cap of $14.30 billion, a price-to-earnings ratio of 62.14, a PEG ratio of 1.96 and a beta of 0.83. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.27 and a quick ratio of 0.78.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.10 by $0.11. The firm had revenue of $1.08 billion for the quarter, compared to analyst estimates of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The company's revenue was up 7.9% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.96 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Equities research analysts anticipate that Cooper Companies will post 4.63 EPS for the current year.

Institutional Trading of Cooper Companies

Hedge funds and other institutional investors have recently bought and sold shares of the business. New York Life Investment Management LLC grew its holdings in shares of Cooper Companies by 0.6% in the fourth quarter. New York Life Investment Management LLC now owns 27,344 shares of the medical device company's stock valued at $2,241,000 after acquiring an additional 158 shares in the last quarter. Root Financial Partners LLC lifted its holdings in Cooper Companies by 104.5% during the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company's stock worth $26,000 after acquiring an additional 162 shares during the period. Essential Partners LLC boosted its position in Cooper Companies by 23.4% in the first quarter. Essential Partners LLC now owns 874 shares of the medical device company's stock worth $62,000 after purchasing an additional 166 shares during the last quarter. Allworth Financial LP grew its stake in Cooper Companies by 14.1% in the 4th quarter. Allworth Financial LP now owns 1,355 shares of the medical device company's stock valued at $111,000 after purchasing an additional 167 shares during the period. Finally, Blue Trust Inc. raised its stake in shares of Cooper Companies by 13.9% during the 4th quarter. Blue Trust Inc. now owns 1,515 shares of the medical device company's stock worth $124,000 after purchasing an additional 185 shares during the period. Institutional investors own 24.39% of the company's stock.

Cooper Companies Company Profile

Cooper Companies, Inc NASDAQ: COO is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women's health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source